Literature DB >> 25696769

Essential thrombocythaemia as cause of myocardial infarction.

A Derks, M H Bloemer.   

Abstract

Abnormalities in the number and function of platelets may contribute to thromboembolic complications in patients with essential thrombocythaemia (ET). Rarely this can lead to an acute myocardial ischaemic syndrome. We describe a young patient with a myocardial infarction, in whom ET was found as the probable cause. We discuss the clinical presentation of ET and the therapeutic possibilities.

Entities:  

Keywords:  essential thrombocythaenia; myocardial infarction; treatment

Year:  2001        PMID： 25696769      PMCID： PMC2504434     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


  17 in total

1.  Myocardial infarction and multiple thromboses in a child with primary thrombocytosis.

Authors:  M S SPACH; D A HOWELL; J S HARRIS
Journal:  Pediatrics       Date:  1963-02       Impact factor: 7.124

2.  Essential thrombocythaemia and recurrent myocardial infarction.

Authors:  P Douste-Blazy; M J Taudou; M Delay; J Pris; P Sie; L Ribaut; F Galinier; P Bernadet
Journal:  Lancet       Date:  1984-10-27       Impact factor: 79.321

Review 3.  Primary thrombocythemia: diagnosis, clinical manifestations and management.

Authors:  P J van Genderen; J J Michiels
Journal:  Ann Hematol       Date:  1993-08       Impact factor: 3.673

4.  Thrombocytosis and fatal coronary heart disease.

Authors:  J E Saffitz; E R Phillips; P N Temesy-Armos; W C Roberts
Journal:  Am J Cardiol       Date:  1983-09-01       Impact factor: 2.778

5.  Thrombocythemia and myocardial ischemia with normal coronary angiogram.

Authors:  I Barr; P Cohen; A Berken; B Lown
Journal:  Arch Intern Med       Date:  1974-09

Review 6.  Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.

Authors:  J J Michiels; J Kutti; P Stark; M Bazzan; L Gugliotta; R Marchioli; M Griesshammer; P J van Genderen; J Brière; J J Kiladjian; T Barbui; G Finazzi; N I Berlin; T C Pearson; A C Green; S M Fruchtmann; R T Silver; E Hansmann; A Wehmeier; E Lengfelder; R Landolfi; H M Kvasnicka; H Hasselbalch; F Cervantes; J Thiele
Journal:  Neth J Med       Date:  1999-02       Impact factor: 1.422

7.  Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis.

Authors:  S Cortelazzo; G Finazzi; M Ruggeri; O Vestri; M Galli; F Rodeghiero; T Barbui
Journal:  N Engl J Med       Date:  1995-04-27       Impact factor: 91.245

8.  Thrombocytosis, coronary thrombosis and acute myocardial infarction.

Authors:  R Virmani; M A Popovsky; W C Roberts
Journal:  Am J Med       Date:  1979-09       Impact factor: 4.965

9.  Myocardial infarction and polycythemia vera: how should we treat it?

Authors:  P Venegoni; G Schroth
Journal:  Cathet Cardiovasc Diagn       Date:  1994-07

10.  Coronary artery bypass grafting for left main trunk coronary artery lesion associated with essential thrombocythemia.

Authors:  T Momiyama; T Hiranaka; F Nomura; H Tominaga; T Nishioka
Journal:  Clin Cardiol       Date:  1993-09       Impact factor: 2.882
View more
  1 in total

1.  What cardiologists should know about essential thrombocythemia and acute myocardial infarction: report of two cases and advanced heart failure therapies considerations.

Authors:  Marie-Camille Soucy-Giguère; Pierre Yves Turgeon; Mario Sénéchal
Journal:  Int Med Case Rep J       Date:  2019-08-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.